Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 6 - The Untold Story

Is It Time to Buy the Dip in Novo Nordisk Stock?

Novo Nordisk stock is down nearly 50% in 2025 as competition in the GLP-1 space continues to mount, but the fundamental case for the NVO stock is growing

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?

Shares of Eli Lilly just got walloped. So, is the company still the name to own in GLP-1s, or are the tables turning on this pharma giant?

CVS customers can get weight-loss drug Wegovy at a discount for cash

CVS customers can get weight-loss drug Wegovy at a discount for cash

But you'll have to pay cash.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

What Are Wall Street Analysts' Target Price for CVS Health Stock?

While CVS Health has outperformed the broader market this year, Wall Street analysts are strongly bullish about its future potential.

Stocks Soar Before the Open on Upbeat Microsoft and Meta Results, More Big Tech Earnings on Tap

June S&P 500 E-Mini futures (ESM25) are up +1.18%, and June Nasdaq 100 E-Mini futures (NQM25) are up +1.68% this morning as forecast-beating quarterly results from Microsoft and Meta boosted sentiment.

Rite Aids could be closing down as company eyes second bankruptcy in two years

The troubled drugstore chain previously filed for Chapter 11 bankruptcy in 2023, which resulted in more than 800 store closures

The Independent UK

CVS Health Earnings Preview: What to Expect

CVS Health is scheduled to report its first-quarter results next month, and analysts expect a double-digit earnings growth.

inkl

Read news from The Economist, FT, and more,
with one subscription

Walgreens to pay up to $350 million in U.S. opioid settlement

Walgreens to pay up to $350 million in U.S. opioid settlement

Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, who accused the pharmacy of illegally filling millions of prescriptions in the last decade for opioids and other controlled substances

The Independent UK

2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs

2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs

Health insurance stocks are outperforming the benchmark indices in 2025, as these two tariff-free and recession-resistant carriers are up 16% and 54%.

Top 3 S&P 500 Winners in a Losing Market

Top 3 S&P 500 Winners in a Losing Market

Despite a broad market correction in 2025, three S&P 500 stocks have defied the downturn, delivering standout performance and showcasing strong fundamentals.

Watch Your Brain Glitch Looking At These 22 Bizarre Discoveries

Watch Your Brain Glitch Looking At These 22 Bizarre Discoveries

Buckle up, because we're about to dive into the section where product designers clearly said "reality is boring" and chose chaos instead.

Watch Your Brain Glitch Looking At These 22 Bizarre Discoveries

Watch Your Brain Glitch Looking At These 22 Bizarre Discoveries

Buckle up, because we're about to dive into the section where product designers clearly said "reality is boring" and chose chaos instead. The post Watch Your Brain Glitch Looking At These 22 Bizarre Discoveries first appeared on Bored Panda.

4 Healthcare Stocks With Massive Gains—and More to Come

4 Healthcare Stocks With Massive Gains—and More to Come

Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.

The 'menopause penalty': Many women in midlife see a drop in wages, new study finds

The 'menopause penalty': Many women in midlife see a drop in wages, new study finds

A new study asserts that women experience a drop in earnings at the end of their child-bearing years.

Get all your
news in one place.

100's of premium titles.
One news app.

This 1 Unlikely Dividend Stock Is the Top S&P 500 Company in 2025. Should You Buy It Now?

As trade wars continue to rattle markets, this unexpected S&P 500 stock is defying the market turbulence and emerging as a winner in 2025.

These Are the 3 Top-Performing Dividend Stocks So Far in 2025

Despite recent market volatility, select dividend stocks thrive, offering yield, growth, and stability.

These 3 Dividend Stocks Jumped 15% in a Month—More to Come?

Dividend stocks aren't just for long-term income generation. These three shares have jumped 15% in one month while also offering dividend payouts.

The Independent UK

CVS is opening more standalone pharmacies after shuttering 1,000 stores

CVS will open a dozen new stores, but they’ll be half the size of a typical location

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Texas cities run short of MMR vaccine as measles outbreak drives demand

Pharmacies are struggling with supplies as fatal outbreak expands and health secretary sows disinformation

3 Dividend Stocks To Buy and Survive a Market Crash

Defensive sectors like consumer staples, healthcare, and utilities offer stability during downturns. Three top-rated picks were identified for their resilience, high yields, and growth potential.

Is CVS Health Stock Outperforming the S&P 500?

CVS Health has outperformed the broader S&P Index’s performance over the past year, and analysts remain strongly upbeat about the stock’s prospects.

93 Receipts That Prove You Should Always Check The Fine Print (New Pics)

On an average day, there’s not much about receipts that’s particularly exciting. But sometimes, if you check the fine print, you’ll find more than just numbers. The post 93 Receipts That Prove You Should Always Check The Fine Print (New Pics) first appeared on Bored Panda.

3 Beaten Down Healthcare Stocks Recovering in 2025

Healthcare stocks took a tumble in 2024 as rising medical costs did a number on margins and profitability, but 2025 may be the year they rebound.

This Dividend Stock Is Up 45% in 2025. Is It Too Late to Buy Shares Now?

CVS stock has surged 45% in 2025, driven by strong Q4 earnings, a new CEO, and strategic innovations.

CVS Health: Earnings Beat Ignites Stock Rally

CVS Health's stock is showing upward movement after exceeding quarterly earnings expectations, suggesting a potential positive shift.

1 … 5 6 7 8

People

185,149 stories

Robert F. Kennedy Jr

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Amazon.com Inc.

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

367,143 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play